AzithromycinThird Party Manufacturing in India

Azithromycin works by binding to the 50S ribosomal subunit of susceptible microorganisms, thereby preventing the translocation of peptides and inhibiting bacterial protein synthesis.

Specifically, it binds to the 23S rRNA of the 50S ribosomal subunit. This blocks RNA-dependent protein synthesis, stopping bacterial cell growth and division. By halting protein synthesis, azithromycin displays bacteriostatic activity, although it can be bactericidal against select organisms at higher concentrations. Its unique chemical structure allows it to accumulate in high concentrations inside lysosomes and phagocytes, which then transport the drug directly to the site of infection.

Unlike older macrolides such as erythromycin, Azithromycin exhibits greater acid stability, which allows for better oral absorption. It also has a significantly longer half-life and achieves much higher intracellular concentrations, making short 3-day or 5-day treatment regimens highly effective for a wide variety of systemic infections.

Therapeutic Uses

Azithromycin is prescribed for the treatment of:

• Severe Respiratory Tract Infections: Used in hospitalized patients for community-acquired pneumonia and pelvic inflammatory disease requiring initial intravenous therapy.
• Pediatric Otitis Media: The oral suspension is widely used in pediatric patients for acute middle ear infections.
• Tonsillitis and Pharyngitis: Used to treat streptococcal throat infections in children and patients allergic to penicillin.
• Uncomplicated Skin Infections: Treats mild-to-moderate skin infections caused by susceptible pathogens.

Why Manufacturers Choose Azithromycin

Azithromycin in sterile injectable and oral liquid suspension forms is a critical product category for pharmaceutical companies. The injection format is essential for severe, acute infections where oral administration is not viable, while the oral suspension is the standard of care for pediatric anti-infective treatment.

For third party manufacturing in India, Azithromycin represents a high-volume, reliable antibiotic option. Partnering with a WHO-GMP certified manufacturer ensures optimal particle size control for oral suspension reconstitution and sterile processing standards for vials. This guarantees that your formulations meet international quality parameters for both domestic PCD distribution and competitive export markets.

This makes Azithromycin injections and suspensions highly demanded for third party manufacturing in India, with consistent orders from established healthcare brands.